ArticleTherapeutic advances in hematology2022

Safety and immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in patients with chronic lymphocytic leukemia: a prospective study.

Panagiotis T Diamantopoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.